维普中文期刊产品整合服务
12篇 您的检索式:作者名="Fuster A B"
    题名 作者 年代 出处 被引量
1BCLC策略:预后预测和治疗推荐2022版更新显示文摘2018版BCLC预后和治疗推荐策略发布后,肝细胞癌(简称HCC)的研究又取得了重大进展。本次更新基于肝癌各领域的研究进展结果。重点关注影响策略的重要研究进展。虽然近年的研究结果成绩斐然,但将其引入为临床医生和研究者提供行动依据的循证模型指南来说证据效力依然不够确切。本文对该问题进行分析,阐述了为HCC患者制定个体化治疗临床决策所需的批判性思维和专业知识。Reig M Forner A Rimola J Ferrer-Fabrega J Burrel M Garcia-Criado A Kelley RK Galle PR Mazzaferro V Salem R Sangro B Singal AG Vogel A Fuster J Ayuso C Bruix J 刘永凡(摘译) 崔笑(摘译) 耿小平(审校) 2022肝胆外科杂志2022,30,5:80
2在没有危险因素的情况下,正常的低密度脂蛋白胆固醇水平与亚临床动脉粥样硬化相关显示文摘普遍认为缺乏心血管病危险因素(cardiovascular risk factors,CVRF)人群的动脉粥样硬化发生风险低,然而,无CVRF的个体仍然有心血管事件发生。为了确定无CVRF个体中亚临床动脉粥样硬化的预测因子,Fernández-Friera L Fuster V López-Melgar B Oliva B García-Ruiz JM Mendiguren J Bueno H Pocock S Ibánez B Fernández-Ortiz A Sanz J 刘莉 叶鹏 2017中华高血压杂志2017,25,12:17
3ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text:a report of the American College of Cardiology/A- merican Heart Association Task Force on practice guide- lines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society 显示文摘Fuster V Ryd6n L E Cannom D S Crijns H J Curtis A B Ellenbogen K A 2006Europace2006,8,:1
4Attentional Biases and Vulnerability to Depression显示文摘Perez M G Barnos Rivera R M Fuster A B 1999Spanish Journal of Psychology1999,2,1:1
5Select clinical trials of erlotinib (OSI2 774) in non-small-cell lung cancer with emphasis on phase III out comes 显示文摘Fuster L M Sandier A B 2004Clin Lung Cancer2004,6,1:1
6Attentional Bias sand Vulnerability to Depression显示文摘Perez M G Banos Rivera R M Fuster A B et a1 1999Spanish Journal of Psychology1999,2,1:1
7Intracellular cytokine pro- file of T lymphocytes in patients with chronic obstructive pul- monary disease显示文摘Barcelo B Pons J Fuster A 2006Clin Exp Immunol2006,145,3:1
8Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease显示文摘Barcel B Pons J Fuster A 2006Clin Exp Immunol2006,145,3:1
9Intraeellular cytokine proile of T lymphocytes in patients with chronic obstructive pulmonary disease显示文摘Barcelo B Prons J Fuster A 2006Clin Erp ]mmunal2006,145,3:1
10Intracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary disease 显示文摘Barcelo B Ports J Fuster A 2006Clin Exp Immunol2006,145,3:1
11Intracellular cytokine profile of Tlymphocytes in patients with chronic obstructive pulmonary disease显示文摘Barcelo B Prons J Fuster A 2006Clin Exp Immunol2006,145,3:1
12Select clinical trials of erlotinib( OSI -774) in non-small-cell lung cancer with emphasis on phase Ⅲ outcomes 显示文摘Fuster L M Sandier A B 2004Clin Lung Cancer2004,6,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费